Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Replimune (REPL) Operating Expenses (2017 - 2025)

Replimune has reported Operating Expenses over the past 9 years, most recently at $71.9 million for Q4 2025.

  • Quarterly results put Operating Expenses at $71.9 million for Q4 2025, up 8.86% from a year ago — trailing twelve months through Dec 2025 was $325.9 million (up 35.2% YoY), and the annual figure for FY2025 was $261.6 million, up 11.44%.
  • Operating Expenses reached $71.9 million in Q4 2025 per REPL's latest filing, down from $84.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $90.4 million in Q2 2025 and bottomed at $22.2 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $56.1 million (2023), compared with a mean of $53.0 million.
  • The largest annual shift saw Operating Expenses surged 65.67% in 2023 before it dropped 7.7% in 2024.
  • Over 5 years, Operating Expenses stood at $29.7 million in 2021, then soared by 40.18% to $41.6 million in 2022, then surged by 35.82% to $56.5 million in 2023, then increased by 16.77% to $66.0 million in 2024, then grew by 8.86% to $71.9 million in 2025.
  • Business Quant data shows Operating Expenses for REPL at $71.9 million in Q4 2025, $84.3 million in Q3 2025, and $90.4 million in Q2 2025.